0
0
10/13/22 at 2:00am
Organization
Mims.com
Author
Audrey Abella
43 words
0
Comments
Using the Steno T1 Risk Engines, the dual SGLT*1 and SGLT2 inhibitor sotagliflozin showed potential in reducing the risk of cardiovascular (CV) and re...
You are the first to view
https://specialty.mims.com/topic/sotagliflozin-may-offer-cardiorenal-protection-for-adults-with-t1d
Create an account
or login to join the discussion